NextCure (NXTC) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

NXTC is expected to report earnings to fall 32.73% to -37 cents per share on October 31

Q3'24

Est.

$-0.37

Q2'24

Missed

by $0.17

Q1'24

Missed

by $0.17

Q4'23

Est.

$-0.52

Q3'23

Beat

by $0.15

The last earnings report on August 01 showed earnings per share of -55 cents, missing the estimate of -37 cents. With 10.03K shares outstanding, the current market capitalization sits at 38.61M.

View a ticker or compare two or three

Compare

NXTC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NXTC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9000 Virginia Manor Road

Phone

+1 240 399-4900

Employees

Web

https://www.nextcure.com